Cytiva 是全球生命科学的先行者,旨在促进和加速医疗药剂的开发和生产。我们是原通用电气医疗集团生命科学事业部的一部分,拥有数百年的悠久历史,而 2020 年对我们来说将开启全新篇章。
我们客户的事业与生命息息相关,贯穿从基础生物学研究到创新型疫苗的研发,从生物医药到新型细胞与基因疗法的研发。
我们所提供的产品与服务成为了客户强有力的后盾,帮助他们加速研究、降本增效,从而为患者带来福利。
Cytiva思拓凡是全球生命科学领域的先行者,在全球40余个国家和地区拥有8000名员工,致力于推进未见技术,加速非凡疗法。作为客户可信赖的合作伙伴,Cytiva专注于生命科学和生物技术的研究,用以开发创新型疫苗、生物药物以及新型细胞和基因疗法。通过提升药物研发和生物工艺的速度、效率和能力,为惠及全球患者开发和生产变革性药物和疗法。
Cytiva is a global pioneer in life sciences, aiming to promote and accelerate the development and production of medical drugs. We are part of the Life Sciences Division of the former GE Healthcare Group, with a long history of hundreds of years, and 2020 will open a new chapter for us.
The cause of our customers is closely related to life, from basic biology research to innovative vaccine research and development, from biomedicine to new cell and gene therapy research and development.
Our products and services have become a strong backing for customers to help them accelerate research, reduce costs and increase efficiency, so as to bring benefits to patients.
Cytiva Situo is a global pioneer in the field of life sciences. With 8000 employees in more than 40 countries and regions around the world, cytiva Situo is committed to promoting advanced technology and accelerating extraordinary therapy. As a reliable partner for customers, cytiva focuses on the research of life science and biotechnology to develop innovative vaccines, biological drugs and new cell and gene therapies. Develop and produce transformative drugs and therapies for patients worldwide by improving the speed, efficiency and capacity of drug R & D and biotechnology.
Cytiva is a global pioneer in life sciences, aiming to promote and accelerate the development and production of medical drugs. We are part of the Life Sciences Division of the former GE Healthcare Group, with a long history of hundreds of years, and 2020 will open a new chapter for us.
The cause of our customers is closely related to life, from basic biology research to innovative vaccine research and development, from biomedicine to new cell and gene therapy research and development.
Our products and services have become a strong backing for customers to help them accelerate research, reduce costs and increase efficiency, so as to bring benefits to patients.
Cytiva Situo is a global pioneer in the field of life sciences. With 8000 employees in more than 40 countries and regions around the world, cytiva Situo is committed to promoting advanced technology and accelerating extraordinary therapy. As a reliable partner for customers, cytiva focuses on the research of life science and biotechnology to develop innovative vaccines, biological drugs and new cell and gene therapies. Develop and produce transformative drugs and therapies for patients worldwide by improving the speed, efficiency and capacity of drug R & D and biotechnology.